Yong Xu
- Molecular Biology top 2%
- Oncology top 5%
- Organic Chemistry top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Lin FuYan ZhangKe DingRenxiao WangLuhua LaiXun LiYuan ZhaoXinglong Zhang
- Topics
- Protein Degradation and Inhibitors (31 papers)Multiple Myeloma Research and Treatments (24 papers)Ubiquitin and proteasome pathways (19 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Yong Xu
164 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Molecular Biology 2.9k
- Oncology 729
- Organic Chemistry 716
- Cancer Research 540
- Pulmonary and Respiratory Medicine 401
Countries citing papers authored by Yong Xu
This map shows the geographic impact of Yong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Xu more than expected).
Fields of papers citing papers by Yong Xu
This network shows the impact of papers produced by Yong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Xu. The network helps show where Yong Xu may publish in the future.
Co-authorship network of co-authors of Yong Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yong Xu. A scholar is included among the top collaborators of Yong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Xu. Yong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 104 | |
| 4 | 7 | |
| 5 | 8 | |
| 6 | 20 | |
| 7 | 11 | |
| 8 | 5 | |
| 9 | 17 | |
| 10 | 17 | |
| 11 | 55 | |
| 12 | 20 | |
| 13 | 20 | |
| 14 | 49 | |
| 15 | 20 | |
| 16 | 34 | |
| 17 | 49 | |
| 18 | 20 | |
| 19 | Effect of PKA on the cytotoxicity of transmembrane and secretory tumor necrosis factor-alpha | 2 |
| 20 | Pharmacokinetics of ungeremine acetate in rats | 1 |
About Yong Xu
Yong Xu is a scholar working on Hematology, Molecular Biology and Pharmacology, having authored 171 papers that have together received 5.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (31 papers), Multiple Myeloma Research and Treatments (24 papers) and Ubiquitin and proteasome pathways (19 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Cancer Research (540 citations) and Oncology (729 citations). Yong Xu has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Lin Fu, Yan Zhang, Ke Ding, Renxiao Wang, Luhua Lai, Xun Li, Yuan Zhao, Xinglong Zhang, Tiejun Cheng and Yan Li. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.